A comparative study of prothrombin complex concentrates and freshfrozen plasma for warfarin reversal under static and flow conditions

Thrombosis and Haemostasis

Volumn 106, Issue 6, 2011, Pages 1215-1223

  Ogawa, Satoru ^a   Szlam, Fania ^a   Ohnishi, Tomoko ^b   Molinaro, Ross J ^a   Hosokawa, Kazuya ^b   Tanaka, Kenichi A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fujimori Kogyo CO   (Japan)

Author keywords

Blood products; Factor concentrates; Thrombosis; Vitamin k dependent factors

Indexed keywords

BERIPLEX; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9 COMPLEX; FRESH FROZEN PLASMA; PROTHROMBIN; PROTHROMBIN COMPLEX; THROMBIN; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INTERNATIONAL NORMALIZED RATIO; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOGENESIS;

ACUTE LUNG INJURY; ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; BLOOD FLOW VELOCITY; DRUG SUBSTITUTION; HEMOSTATICS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; PLASMA; PROTHROMBIN TIME; THROMBOSIS; WARFARIN;

EID: 82555175356     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-04-0240     Document Type: Article

References (37)

1. Holland L, Warkentin TE, Refaai M, et al. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-1177.
2. Chowdhury P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30 ml/ kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
3. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46: 1279-1285.
4. Makris M. Optimisation of the prothrombin complex concentrate dose for warfarin reversal. Thromb Res 2005; 115: 451-453.
5. Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010; 8: 149-154.
6. Leissinger CA, Blatt PM, Hoots WK, et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008; 83: 137-143.
7. Levy JH, Tanaka KA, Dietrich W. Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology 2008; 109: 905-917.
8. Demeyere R, Gillardin S, Arnout J, et al. Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study. Vox Sang 2010; 99: 251-260.
9. Segal JB, Dzik WH, Network TMHCT. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-1425.
10. Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science 1980; 207: 541-543.
11. Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 1998; 92 (Suppl 2): S25-31.
12. Tomokiyo K, Kamikubo Y, Hanada T, et al. Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions. Blood 2005; 105: 1078-1084.
13. Aarts PA, van den Broek SA, Prins GW, et al. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis 1988; 8: 819-824.
14. Hosokawa K, Ohnishi T, Kondo T, et al. A Novel Automated Microchip Flow- Chamber System to Quantitatively Evaluate Thrombus Formation and Antithrombotic Agents Under Blood Flow Conditions. J Thromb Haemost 2011; 9: 2029-2037.
15. Allen GA, Wolberg AS, Oliver JA, et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2004; 2: 402-413.
16. Tanaka KA, Szlam F, Dickneite G, et al. Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res 2008; 122: 117-123.
17. Kroll MH, Hellums JD, McIntire LV, et al. Platelets and shear stress. Blood 1996; 88: 1525-1541.
18. Cross-sectional guidelines for therapy with blood components and plasma derivatives: Chapter 7 Procoagulators. Transfus Med Hemother 2009; 36: 419-436.
19. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
20. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007; 131: 1308-1314.
21. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477-480.
22. Yasaka M, Sakata T, Minematsu K, et al. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 2002; 108: 25-30.
23. Evans G, Luddington R, Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 2001; 115: 998-1001.
24. Samama CM. Prothrombin complex concentrates: a brief review. European Journal of Anaesthesiology 2008; 25: 784-789.
25. Tokarev AA, Butylin AA, Ataullakhanov FI. Platelet adhesion from shear blood flow is controlled by near-wall rebounding collisions with erythrocytes. Biophys J 2011; 100: 799-808.
26. Acharya SS, Coughlin A, Dimichele DM. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-256.
27. Pabinger I, Brenner B, Kalina U, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 2008; 6: 622-631.
28. Xi M, Beguin S, Hemker HC. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost 1989; 62: 788-791.
29. Andrew M, Schmidt B, Mitchell L, et al. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63: 27-30.
30. Bossavy JP, Sakariassen KS, Thalamas C, et al. Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis: effect of anticoagulation level and combination therapy with aspirin. Arterioscler Thromb Vasc Biol 1999; 19: 2269-2275.
31. Riess HB, Meier-Hellmann A, Motsch J, et al. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 2007; 121: 9-16.
32. Sarode R, Rawal A, Lee R, et al. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Br J Haematol 2006; 132: 604-607.
33. Skolnick BE, Mathews DR, Khutoryansky NM, et al. Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects. Blood 2010; 116: 693-701.
34. Vigue B, Ract C, Tremey B, et al. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med 2007; 33: 721-725.
35. Gatt A, Riddell A, van Veen JJ, et al. Optimizing warfarin reversal--an ex vivo study. J Thromb Haemost 2009; 7: 1123-1127.
36. Aird WC. Endothelial cell dynamics and complexity theory. Crit Care Med 2002; 30: S180-185.
37. Johne J, Blume C, Benz PM, et al. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol Chem 2006; 387: 173-178.